Metraipolis › archive › dc_bca035c0df65

Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation — Europe PMC PMID:41201142

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41201142
DOI
10.1002/smll.202505605
License (as archived)
solo-consultazione
Archived
2026-11-08T18:02:02.751Z
SHA-256 of the archived text
7511adcdc9626c15eeff4e4baf2cc51e3c805d013ee9ea8ebf19fa58770682f1
Stable URL of this page
https://metraipolis.com/documento/dc_bca035c0df65

How to cite

Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation — Europe PMC PMID:41201142 — Europe PMC (en), https://europepmc.org/article/MED/41201142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bca035c0df65 (Metraipolis archive dc_bca035c0df65, sha256 7511adcdc9626c15eeff4e4baf2cc51e3c805d013ee9ea8ebf19fa58770682f1)
BibTeX
@misc{dcbca035c0df65,
  title = {Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation — Europe PMC PMID:41201142},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41201142},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bca035c0df65; sha256 7511adcdc9626c15eeff4e4baf2cc51e3c805d013ee9ea8ebf19fa58770682f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41201142. Agents can read the archived copy with the MCP tool read_document.